When is chemotherapy used in NSCLC?

Chemotherapy

Chemotherapy (chemo) is treatment with anti-cancer drugs that may be injected into a vein or taken by mouth. Chemo drugs for lung cancer are typically given into a vein (IV), either as an injection over a few minutes or as an infusion over a longer period of time. This can be done in a doctor’s office, chemotherapy clinic, or in a hospital setting.

These drugs travel through the bloodstream and reach most parts of the body. Depending on the cancer’s stage and other factors, chemo may be recommended in different situations, such as before or after surgery. Neoadjuvant chemo is used before surgery (sometimes with radiation therapy). Adjuvant chemo is used after surgery (sometimes with radiation therapy) to try to kill any cancer cells that might have been left behind. Your doctor will tell you about the timing of your cycle and the number of cycles you will get.

Doctors give chemo in cycles that usually include a treatment period plus a rest period. Most cycles are 3 or 4 weeks long.

Adjuvant and neoadjuvant chemo is often given for 3 to 4 months, depending on the drugs used. The length of treatment for advanced lung cancer is based on how well it is working and what side effects you have.

Chemotherapy for NSCLC

The chemo drugs most often used for NSCLC include:

  • Cisplatin
  • Carboplatin
  • Paclitaxel (Taxol®)
  • Albumin-bound paclitaxel (Abraxane®)
  • Docetaxel (Taxotere®)
  • Gemcitabine (Gemzar®)
  • Vinorelbine (Navelbine®)
  • Etoposide (VP-16)
  • Pemetrexed (Alimta®)

More than one chemo drug may be used to treat early-stage lung cancer. Often cisplatin or carboplatin plus one other drug. Sometimes other drugs are combined, such as gemcitabine with vinorelbine or paclitaxel.

Advanced lung cancer is also called stage IV or metastatic cancer. It means that the cancer has spread to places in your body outside of the lungs. Advanced lung cancer may be treated with a single drug, especially for people who might not tolerate more than one drug well, such as those in poor overall health.

For some people with advanced lung cancer, a targeted therapy or an immunotherapy drug may be given along with chemotherapy.

For advanced cancer, the initial chemo combination is often given for four to six cycles. Some doctors now recommend giving treatment beyond this with a single drug, for people who’s tumor has gotten smaller or has not grown. This is called maintenance therapy. It helps to keep the cancer from growing.

If the first chemo drug (or drugs) do not work or stop working, your doctor may talk to you about using different medicine.

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Search

[divi_global_search_form]

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for retinopathy of prematurity (ROP). Click on one of the options below to learn more about ROP.

Patient Toolkit

Patient Toolkit

Read more

What exactly is NSCLC?

What exactly is NSCLC?

Read more

What symptoms can NSCLC cause?

What symptoms can NSCLC cause?

Read more

How is NSCLC treated according to staging?

How is NSCLC treated according to staging?

Read more

How is early NSCLC treated with surgery or SBRT?

How is early NSCLC treated with surgery or SBRT?

Read more

When is chemotherapy used in NSCLC?

When is chemotherapy used in NSCLC?

Read more

When is radiation used in NSCLC?

When is radiation used in NSCLC?

Read more

When is immunotherapy used in NSCLC?

When is immunotherapy used in NSCLC?

Read more

When is targeted therapy used in NSCLC?

When is targeted therapy used in NSCLC?

Read more

Online resources

Online resources

Read more
This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM). This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | ROP Relief | All Rights Reserved | Website by Divigner